{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T17:56:45Z","timestamp":1793642205724,"version":"4.5.1"},"reference-count":8,"publisher":"Elsevier BV","issue":"23","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,13]],"date-time":"2025-06-13T00:00:00Z","timestamp":1749772800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JACC: Case Reports"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.jaccas.2025.104647","type":"journal-article","created":{"date-parts":[[2025,8,13]],"date-time":"2025-08-13T18:54:31Z","timestamp":1755111271000},"page":"104647","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Successful Rituximab Treatment of GPIHBP1 Autoantibody-Associated Hypertriglyceridemia"],"prefix":"10.1016","volume":"30","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4101-3687","authenticated-orcid":false,"given":"Tasmeen","family":"Hussain","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Audra","family":"Horomanski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sneha","family":"Jain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cindy","family":"Lamendola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fahim","family":"Abbasi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masami","family":"Murakami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua W.","family":"Knowles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"17","key":"10.1016\/j.jaccas.2025.104647_bib1","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1056\/NEJMoa1611930","article-title":"Autoantibodies against GPIHBP1 as a cause of hypertriglyceridemia","volume":"376","author":"Beigneux","year":"2017","journal-title":"N Engl J Med"},{"issue":"11","key":"10.1016\/j.jaccas.2025.104647_bib2","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1194\/jlr.R120001116","article-title":"Chylomicronemia from GPIHBP1 autoantibodies","volume":"61","author":"Miyashita","year":"2020","journal-title":"J Lipid Res"},{"issue":"1","key":"10.1016\/j.jaccas.2025.104647_bib3","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.jacl.2018.10.004","article-title":"GPIHBP1 autoantibody syndrome during interferon \u03b21a treatment","volume":"13","author":"Eguchi","year":"2019","journal-title":"J Clin Lipidol"},{"issue":"1","key":"10.1016\/j.jaccas.2025.104647_bib4","doi-asserted-by":"crossref","first-page":"e80","DOI":"10.1016\/j.jacl.2023.11.002","article-title":"Molecular genetic testing and measurement of levels of GPIHBP1 autoantibodies in patients with severe hypertriglyceridemia: the importance of identifying the underlying cause of hypertriglyceridemia","volume":"18","author":"Str\u00f8m","year":"2024","journal-title":"J Clin Lipidol"},{"issue":"3","key":"10.1016\/j.jaccas.2025.104647_bib5","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1038\/s41573-020-00092-2","article-title":"B cell depletion therapies in autoimmune disease: advances and mechanistic insights","volume":"20","author":"Lee","year":"2021","journal-title":"Nat Rev Drug Discov"},{"issue":"2","key":"10.1016\/j.jaccas.2025.104647_bib6","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.jacl.2020.01.012","article-title":"Intermittent chylomicronemia caused by intermittent GPIHBP1 autoantibodies","volume":"14","author":"Ashraf","year":"2020","journal-title":"J Clin Lipidol"},{"issue":"9","key":"10.1016\/j.jaccas.2025.104647_bib7","doi-asserted-by":"crossref","first-page":"764","DOI":"10.7326\/L20-0327","article-title":"Chylomicronemia from GPIHBP1 autoantibodies successfully treated with rituximab: a case report","volume":"173","author":"Lutz","year":"2020","journal-title":"Ann Intern Med"},{"issue":"5","key":"10.1016\/j.jaccas.2025.104647_bib8","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/j.jacl.2022.08.001","article-title":"GPIHBP1 autoantibody is an independent risk factor for the recurrence of hypertriglyceridemia-induced acute pancreatitis","volume":"16","author":"Zhang","year":"2022","journal-title":"J Clin Lipidol"}],"container-title":["JACC: Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666084925014275?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666084925014275?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,8,21]],"date-time":"2025-08-21T02:20:14Z","timestamp":1755742814000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666084925014275"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":8,"journal-issue":{"issue":"23","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["S2666084925014275"],"URL":"https:\/\/doi.org\/10.1016\/j.jaccas.2025.104647","relation":{},"ISSN":["2666-0849"],"issn-type":[{"value":"2666-0849","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Successful Rituximab Treatment of GPIHBP1 Autoantibody-Associated Hypertriglyceridemia","name":"articletitle","label":"Article Title"},{"value":"JACC: Case Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaccas.2025.104647","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier on behalf of the American College of Cardiology Foundation.","name":"copyright","label":"Copyright"}],"article-number":"104647"}}